Practices that had experience with the COME HOME community oncology medical home model didn’t perform any better in the Oncology Care Model (OCM) than other practices, explained Barbara L. McAneny, MD, president of the American Medical Association.
Practices that had experience with the COME HOME community oncology medical home model didn’t perform any better in the Oncology Care Model (OCM) than other practices, explained Barbara L. McAneny, MD, president of the American Medical Association.
Transcript
For the practices in the Oncology Care Model that have succeeded, what are the trends we are seeing in the field? Did they make certain changes or were they already doing all the right things?
I had the Innovation Center [Center for Medicare and Medicaid Innovation] grant of COME HOME, which stands for Community Oncology Medical Home, and we thought that those 7 practices would be extremely well-positioned to do a great job for OCM. OCM built on some of the things that we learned about how to do a better job delivering care to patients, how to do that coordinated care, provide those same-day visits and other things that kept patients out of the hospital, and therefore save money. We saved a lot of money in COME HOME per patient. Those practices have not done any better than others. It seems to be a random event and I think there are 2 parts to that. There’s probably more than 2, but there are 2 parts.
The first is that as CMS has created their target prices that we’re to aim for they are not sufficiently accurate. So, we took all of the data we had from the COME HOME, from 16,000 sets of claims and we compared what patients actually cost the system to what the OCM target was and we found that the correlation factor, the R2 value, was 0.33. If you flip a coin, it should be 0.5. If you have a model that you’re going to base an economic decision on, it should be better than 0.75. So, the fact that the value was 0.33 tells me that it’s more or less a random event whether you’re going to hit that target. And I’m not willing to bet my practice on a random event.
If we do, if practices took 2-sided risk and then had to pay back money to Medicare because a patient had one of these strange reactions to some of the personalized medicine drugs or some other untoward side effect or even got hit by a bus on the way to the office, you would have an event that would be incredibly expensive that would be more than what the practice could afford to pay back.
So, one of our concerns with 2-sided risk is that you may lose a certain fraction of the practices who will either go bankrupt, have to sell to a hospital system to survive, in which case the cost of everything doubles, or just not be able to continue to participate in that model.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More